VRAP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vranken Pommery Monopole SA

Watchlist Manager

Watchlist

Price: 11.45 EUR 1.33% Market Closed

Market Cap: €102.4m

	Vranken Pommery Monopole SA PAR:VRAP	FR
B	Brookdale Senior Living Inc F:B7S	US
I	Innocan Pharma Corp XHAM:IP4	IL
	Royalty Pharma PLC F:RPD	US
I	IPD Group Ltd ASX:IPG	AU

Profitability Summary

Vranken Pommery Monopole SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

50%

Sustainable 3Y Average Gross Margin

50%

Gross Margin is Increasing

48% > 50%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

12%

Declining Operating Margin

12% > 11%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

3% > 0%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.